News | June 23, 2008

Implantable Cardiac Devices Link Up with Medtronic Network

June 25, 2008 - Medtronic reported that all Vision 3D implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds) are now compatible with the Medtronic CareLink Network.

The Medtronic CareLink Network is designed to allow physicians to perform a complete analysis of all the device- and patient-specific cardiac data stored within Medtronic implantable cardiac devices. With this announcement, all current models of Medtronic ICDs, CRT-Ds and pacemakers are compatible with the Medtronic CareLink Network, which has registered more than 1 million patient data transmissions since its inception.

The Medtronic CareLink Network helps physicians and patients better manage chronic cardiovascular disease treated by implantable device therapy. It is said to enable the transmission of patient and implanted device data using a portable monitor. Within minutes, the patient’s physician and nurses can view the data on a secure Internet Web site.
For heart failure patients with Medtronic devices equipped with Conexus Wireless Telemetry – all Vision 3D ICDs and CRT-Ds, as well as Concerto CRT-Ds or Virtuoso ICDs – a Medtronic CareAlert Notification can be sent via the Medtronic CareLink Network to physicians wirelessly and automatically, providing timely insight into a patient’s changing disease condition and the potential for treatment decisions before the condition worsens.
The transmitted information, which is comparable to that provided during an in-clinic device follow-up visit, provides the physician with a view of how both the device and patient’s heart are operating.
The system provides an efficient, safe and convenient way for specialty physicians to remotely monitor the condition of their patients and, if needed, make adjustments to medication or prescribe additional therapy.
It also saves patients time by potentially eliminating some in-office visits.

For more information: www.medtronic.com

Related Content

Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD)| September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Predictive Models May Help Determine Which Patients Benefit From ICDs
News | Implantable Cardioverter Defibrillator (ICD)| July 06, 2017
Two predictive models may help cardiologists decide which patients would most benefit from an implantable cardioverter...
Videos | Implantable Cardioverter Defibrillator (ICD)| June 01, 2017
Lucas Boersma, M.D., Ph.D., FESC, St.
The Unify ICD is one of the SJM devices in an FDA warning letter
Feature | Implantable Cardioverter Defibrillator (ICD)| April 14, 2017 | Dave Fornell
April 14, 2017 — The U.S. Food and Drug Administration (FDA) sent a warning letter to Abbott/St.
ICDs, non-ischemic cardiomyopathy, University of Alabama at Birmingham study, Circulation
News | Implantable Cardioverter Defibrillator (ICD)| January 18, 2017
A new study published in Circulation has found there is a 23 percent risk in reduction of all-cause mortality in non-...
ICDs, implantable cardioverter defibrillators, survival rate, elderly patients, JACC study
News | Implantable Cardioverter Defibrillator (ICD)| January 17, 2017
Of patients over age 65 who received an implantable cardioverter-defibrillator (ICD) after surviving sudden cardiac...
Overlay Init